Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance
Huizhen Wang, Yida Lu, Mingliang Wang, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 2, pp. 193-212
Closed Access | Times Cited: 19

Showing 19 citing articles:

Methylomics and cancer: the current state of methylation profiling and marker development for clinical care
Chengyin Liu, Han Tang, Nana Hu, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Wnt signaling in gastric cancer: current progress and future prospects
Ruyue Han, Jing Yang, Yingying Zhu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Mechanism of cisplatin resistance in gastric cancer and associated microRNAs
Changqing Liu, Shan Li, Yunlian Tang
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 5, pp. 329-340
Closed Access | Times Cited: 12
Ginsenoside RG3 Synergizes With STING Agonist to Reverse Cisplatin Resistance in Gastric Cancer
Zhongqi Lu, Yihang Fu, Qiang Fu, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 1
Open Access
RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer
Ning Li, Dao-fu Shen, Nanchang Yin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review
Zhe‐Sheng Chen, Lizhu Lin, Sheng-Xiong Zhang, et al.
Recent Patents on Anti-Cancer Drug Discovery (2021) Vol. 17, Iss. 1, pp. 26-41
Closed Access | Times Cited: 21
FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy
Shimin Chen, Jichun Lin, Jiaojiao Zhao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies
Maoyu Wang, Zhensheng Zhang, Zhizhou Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Puerarin Suppresses Glycolysis and Increases Cisplatin Chemosensitivity in Oral Squamous Cell Carcinoma via FBXW7/mTOR Signaling
Yu Cai, Qiang Gao, Junhua Meng, et al.
Nutrition and Cancer (2023) Vol. 75, Iss. 3, pp. 1028-1037
Closed Access | Times Cited: 4
Integrative analysis illustrates the role of PCDH7 in lung cancer development, cisplatin resistance, and immunotherapy resistance: an underlying target
Huakang Li, Haoran Xu, Hong Guo, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure–activity relationship
Jing Zeng, Zheng Chen, Yuxin He, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116821-116821
Closed Access | Times Cited: 1
Helicobacter pylori induce circ_0046854 to regulate microRNA‐511‐3p/CSF1 axis and enhance the resistance of gastric cancer to cisplatin
Juan Ma, SiRuo Zhang, Gong Yanyan, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 10
Closed Access | Times Cited: 1
LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma
Yanzhao Jin, Jiaqing Cao, Hua Cheng, et al.
Journal of Chemotherapy (2023) Vol. 35, Iss. 7, pp. 638-652
Closed Access | Times Cited: 3
Glaucocalyxin A Inhibits the Malignancies of Gastric Cancer Cells by Downregulating MDM2 and RNF6 via MiR-3658 and the SMG1-UPF mRNA Decay Pathway
Yanqi Liu, Ping Chen, Daqing Qi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Crosstalk among Alternative Polyadenylation, Genetic Variants and Ubiquitin Modification Contribute to Lung Adenocarcinoma Risk
Yutong Wu, Yanqiong Yuan, Huiwen Xu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8084-8084
Open Access
TRIM47 inhibits cisplatin chemosensitivity and endoplasmic reticulum stress-induced apoptosis of ovarian cancer cells
Jiao Zhao, Jingru Zhang, Xiaojing Tong, et al.
Molecular and Cellular Probes (2024) Vol. 77, pp. 101978-101978
Open Access
E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51
Pian Liu, Wei Zhou, Liu Yang, et al.
Chemico-Biological Interactions (2022) Vol. 354, pp. 109798-109798
Closed Access | Times Cited: 2
Methods to Evaluate the Effects of HAT/KAT Inhibition on SIAH2-Driven Reactive Oxygen Species Generation in Helicobacter pylori-Infected Gastric Epithelial Cells
Pragyesh Dixit, Shrikant Babanrao Kokate, Suvasmita Rath, et al.
Methods in molecular biology (2022), pp. 317-335
Closed Access | Times Cited: 1
Droplet digital polymerase chain reaction assay for methylated ring finger protein 180 in gastric cancer
Guanghong Guo, Yibin Xie, Tao Jiang, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 10, pp. 2038-2047
Open Access
Page 1

Scroll to top